Viewing Study NCT06672068


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-28 @ 3:00 PM
Study NCT ID: NCT06672068
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-30
First Post: 2024-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
Sponsor: TYK Medicines, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module